0001127602-20-007086.txt : 20200224
0001127602-20-007086.hdr.sgml : 20200224
20200224085657
ACCESSION NUMBER: 0001127602-20-007086
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200220
FILED AS OF DATE: 20200224
DATE AS OF CHANGE: 20200224
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ISHRAK OMAR
CENTRAL INDEX KEY: 0001523102
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36820
FILM NUMBER: 20642174
MAIL ADDRESS:
STREET 1: 710 MEDTRONIC PKWY
STREET 2: MS LC300
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55432
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medtronic plc
CENTRAL INDEX KEY: 0001613103
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
FISCAL YEAR END: 0424
BUSINESS ADDRESS:
STREET 1: 20 ON HATCH, LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
BUSINESS PHONE: 01135314381700
MAIL ADDRESS:
STREET 1: 20 ON HATCH, LOWER HATCH STREET
CITY: DUBLIN
STATE: L2
ZIP: 2
FORMER COMPANY:
FORMER CONFORMED NAME: Medtronic Ltd
DATE OF NAME CHANGE: 20150112
FORMER COMPANY:
FORMER CONFORMED NAME: Medtronic Holdings Ltd
DATE OF NAME CHANGE: 20140711
FORMER COMPANY:
FORMER CONFORMED NAME: Kalani I Ltd
DATE OF NAME CHANGE: 20140709
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-02-20
0001613103
Medtronic plc
MDT
0001523102
ISHRAK OMAR
710 MEDTRONIC PKWY MS LC300
MINNEAPOLIS
MN
55432
1
1
Chairman & CEO
Ordinary Shares
2020-02-20
4
P
0
8771
113.68
A
605190
D
Ordinary Shares
18182
I
2019 GRAT
Ordinary Shares
5900
I
2018 GRAT
The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $113.65 to $113.70, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in the footnote to this Form 4.
This balance increased by 1,994 shares due to exempt transactions such as dividend reinvestment.
/s/ Perry F. Sekus, attorney-in-fact
2020-02-24